Electronic Letters to:
|
Electronic letters published:
-
![[Read eLetter]](/icons/misc/sectionDOWN.gif)
NICE Guideline and BODE Index in COPD
- Daniel K C Lee (21 April 2004)
|
|
|||
|
Daniel K C Lee, Respiratory Physician Department of Respiratory Medicine, Ipswich Hospital, Heath Road, Ipswich IP4 5PD, Suffolk, England
Send letter to journal:
dkclee{at}doctors.org.uk Daniel K C Lee
|
Dear Editor The publication of the National Institute for Clinical Excellence (NICE) guideline on the management of chronic obstructive pulmonary disease (COPD) in adults in primary and secondary care [1] is timely and in synchrony with the transatlantic publication of the body-mass index (B), airflow obstruction (O), dyspnoea (D), and exercise capacity (E) index in predicting risk of death in patients with COPD.[2] In fact, measurements of the prognostic factors outlined in the BODE index were recommended by NICE for inclusion in the day-to-day management of COPD, albeit individually as separate entities. The practicality of the BODE index lies in the combination and validation of the most significant of these individual factors into a clinically relevant prognostic indicator. Hand-in-hand, the NICE guideline and the BODE index, will serve to better the management of patients with COPD. References 1. Chronic obstructive pulmonary disease: National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax 2004;59(Suppl 1):1-232. 2. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, Pinto Plata V, Cabral HJ. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004;350:1005-12. |
|||
